- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05701397
Prevalence of Cardiac Amyloidosis in Patients Undergoing Surgery for Lumbar Spinal Stenosis. (CASS-II)
January 26, 2023 updated by: Steen Hvitfeldt Poulsen
Patients undergoing surgery for lumbar spinal stenosis will have biopsies of the ligamentum flavum sent to the department of pathology for histologic screening.
If the ligament biopsy contains amyloid, patients will receive an echocardiogram, an ecg, biomarker testing, and a bone tracer scintigraphy diagnostic of cardiac amyloidosis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bertil Ladefoged
- Phone Number: 40927245
- Email: berlad@rm.dk
Study Locations
-
-
-
Aarhus N, Denmark, 8200
- Recruiting
- Department of Cardiology, Aarhus University Hospital
-
Contact:
- Bertil Ladefoged
- Phone Number: 40927245
- Email: berlad@rm.dk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
65 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Scheduled for surgery for lumbar spinal stenosis
- Age > 65 years
- Informed written consent
Exclusion Criteria:
- Known amyloidosis
- Myelomatosis
- Monoclonal gammopathy of unknown significance, MGUS
- Morbus Waldenstrøm
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
Patients undergoing surgery for lumbar spinal stenosis.
Patients will have a biopsy taken from the ligamentum flavum and test for the presence of amyloid.
Patients with amyloid in the ligamentum flavum will be referred for a DPD scintigraphy.
|
Bone tracer scintigraphy, diagnostic for transthyretin cardiac amyloidsis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Diagnosis of cardiac amyloidosis
Time Frame: 1 year
|
DPD scintigraphy with a Perugini Grade 2 og higher.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2023
Primary Completion (Anticipated)
February 1, 2024
Study Completion (Anticipated)
April 1, 2024
Study Registration Dates
First Submitted
January 16, 2023
First Submitted That Met QC Criteria
January 26, 2023
First Posted (Actual)
January 27, 2023
Study Record Updates
Last Update Posted (Actual)
January 27, 2023
Last Update Submitted That Met QC Criteria
January 26, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1-10-72-116-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Stenosis
-
RTI SurgicalCompletedSpinal Disease | Spinal Instability | Spinal Stenosis Occipito-Atlanto-Axial | Spinal Stenosis Cervical | Spinal Stenosis Cervicothoracic RegionUnited States
-
Azienda Usl di BolognaRecruitingLumbar Spinal Stenosis | Degenerative Lumbar Spinal StenosisItaly
-
Sutherland Medical CenterActive, not recruitingSpinal Stenosis Lumbar | Spinal Canal StenosisPoland
-
Massachusetts General HospitalCompletedLumbar Spinal Stenosis | Thoracic Spinal StenosisUnited States
-
University Hospital, Basel, SwitzerlandKlinik für Radiologie und Nuklearmedizin, University Hospital BaselCompletedLumbar Spinal Stenosis | Symptomatic Lumbar Spinal StenosisSwitzerland
-
Sklifosovsky Institute of Emergency CarePirogov National Medical Surgical Center; Federal State Budgetary Institution... and other collaboratorsActive, not recruitingLumbar Spinal Stenosis | Spinal Stenosis | Spinal FusionRussian Federation
-
Rijnstate HospitalMedical Metrics Diagnostics, IncNot yet recruitingLumbar Spinal Stenosis | Spinal InstabilityNetherlands
-
Region ZealandRegion SyddanmarkRecruiting
-
Tang-Du HospitalNot yet recruiting
Clinical Trials on DPD scintigraphy
-
Steen Hvitfeldt PoulsenRecruitingSpinal Stenosis | Cardiac AmyloidosisDenmark
-
Aarhus University Hospital SkejbyRegional Hospital HolstebroCompletedCarpal Tunnel Syndrome | Amyloidosis CardiacDenmark
-
Steen Hvitfeldt PoulsenRecruitingAmyloid Cardiomyopathy | Block, AVDenmark
-
Universidade do PortoCentro Hospitalar Universitário São João, E.P.E. (CHUSJ); Centro de Investigação... and other collaboratorsRecruitingCarpal Tunnel Syndrome | Transthyretin AmyloidosisPortugal
-
Katarzyna HolcmanRecruitingTransthyretin AmyloidosisPoland
-
University of LeipzigActive, not recruitingHeart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Preserved Ejection Fraction | Hypertrophy, Left Ventricular | Heart Failure NYHA Class IV | Cardiac Amyloidosis | Heart Failure With Mid Range Ejection FractionGermany
-
University Hospital Inselspital, BerneActive, not recruitingAortic Stenosis Symptomatic | Amyloidosis CardiacSwitzerland
-
Centre Antoine LacassagneRecruitingMetastatic or Locally-advanced Digestive CancerFrance
-
Queen Mary University of LondonUnknownAortic Stenosis | Cardiac AmyloidosisUnited Kingdom
-
PfizerTerminatedHeart Failure With Preserved Ejection Fraction | Transthyretin Amyloid CardiomyopathySpain, United States, Japan, Canada, France, Italy, Poland, United Kingdom